Addex Therapeutics (APE1) Income Statement

0 Followers

Addex Therapeutics Income Statement

Last quarter (Q2 2026), Addex Therapeutics's total revenue was CHF9.91K, a decrease of -66.67% from the same quarter last year. In Q2, Addex Therapeutics's net income was CHF-1.74M. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Mar 26	Mar 25	Mar 24	Dec 22	Dec 21
Total Revenue	CHF 29.97K	CHF 404.10K	CHF 1.61M	CHF 1.42M	CHF 2.92M
Gross Profit	CHF 29.97K	CHF 404.10K	CHF 1.61M	CHF 1.42M	CHF 2.92M
Operating Expenses	CHF 2.84M	CHF 3.16M	CHF 3.86M	CHF 11.96M	CHF 18.42M
Depreciation and Amortization	CHF 8.47K	CHF 260.12K	CHF 305.95K	CHF 323.14K	CHF 347.61K
EBITDA	CHF -6.83M	CHF -4.65M	CHF -2.19M	CHF -10.45M	CHF -14.94M
Operating Income	CHF -2.81M	CHF -2.76M	CHF -2.24M	CHF -10.54M	CHF -15.51M
Other Income/Expenses	CHF -4.03M	CHF -2.15M	CHF -257.19K	CHF -263.06K	CHF 154.00K
Pretax Income	CHF -6.84M	CHF -4.91M	CHF -2.50M	CHF -10.80M	CHF -15.35M
Net Income	CHF -6.73M	CHF 7.06M	CHF -10.56M	CHF -20.80M	CHF -15.35M
Per Share Metrics
Basic EPS	CHF -6.88	CHF 8.40	CHF -16.80	CHF -55.20	CHF -54.00
Diluted EPS	CHF -6.88	CHF 8.40	CHF -16.80	CHF -55.20	CHF -54.00
Weighted Average Shares Outstanding	935.00K	817.61K	619.23K	376.54K	284.33K
Weighted Average Shares Outstanding (Diluted)	935.00K	817.61K	619.23K	376.54K	284.33K

Currency in CHF

Addex Therapeutics (APE1) Income Statement

Addex Therapeutics Income Statement

Addex Therapeutics Earnings and Revenue History